CA2984080A1 - Blood glucose management device for calculating bolus insulin - Google Patents

Blood glucose management device for calculating bolus insulin Download PDF

Info

Publication number
CA2984080A1
CA2984080A1 CA2984080A CA2984080A CA2984080A1 CA 2984080 A1 CA2984080 A1 CA 2984080A1 CA 2984080 A CA2984080 A CA 2984080A CA 2984080 A CA2984080 A CA 2984080A CA 2984080 A1 CA2984080 A1 CA 2984080A1
Authority
CA
Canada
Prior art keywords
user
query
insulin
display
memory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2984080A
Other languages
English (en)
French (fr)
Inventor
Jennifer L. GASS
Robert W. Morin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Ascensia Diabetes Care Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings AG filed Critical Ascensia Diabetes Care Holdings AG
Publication of CA2984080A1 publication Critical patent/CA2984080A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
CA2984080A 2015-05-13 2016-05-12 Blood glucose management device for calculating bolus insulin Abandoned CA2984080A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562160892P 2015-05-13 2015-05-13
US62/160,892 2015-05-13
PCT/IB2016/052755 WO2016181351A1 (en) 2015-05-13 2016-05-12 Blood glucose management device for calculating bolus insulin

Publications (1)

Publication Number Publication Date
CA2984080A1 true CA2984080A1 (en) 2016-11-17

Family

ID=56081522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2984080A Abandoned CA2984080A1 (en) 2015-05-13 2016-05-12 Blood glucose management device for calculating bolus insulin

Country Status (6)

Country Link
US (1) US20180130551A1 (https=)
EP (1) EP3295342B1 (https=)
JP (1) JP2018517974A (https=)
CN (1) CN107592931A (https=)
CA (1) CA2984080A1 (https=)
WO (1) WO2016181351A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3198598A1 (en) 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
US11123137B2 (en) * 2018-01-23 2021-09-21 Modulight Oy Method and system for operating biomedical laser
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
FR3100973B1 (fr) 2019-09-25 2023-05-05 Air Liquide Dispositif pour déterminer et afficher une dose d’insuline à administrer à un patient diabétique
EP4088285A4 (en) * 2020-01-08 2024-01-24 Dexcom, Inc. BOLUS DOSE MANAGEMENT
EP4039293A1 (en) * 2021-02-05 2022-08-10 Insulet Corporation Techniques and devices for adaptation of maximum drug delivery limits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078314A1 (en) * 2005-09-30 2007-04-05 Grounsell Richard L System and method for measuring and predicting insulin dosing rates
US20080228056A1 (en) * 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
CA2691826A1 (en) * 2007-07-09 2009-01-15 University Of Virginia Patent Foundation Method, system and computer program product for evaluation of insulin sensitivity, insulin/carbohydrate ratio, and insulin correction factors in diabetes from self-monitoring data
WO2009075925A1 (en) * 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
PT2260423T (pt) * 2008-04-04 2018-05-30 Hygieia Inc Aparelho para optimizar o regime de dosagem de insulina a um paciente
CA3277222A1 (en) * 2011-02-28 2025-10-30 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US20140121634A1 (en) * 2012-07-11 2014-05-01 Caren Frances Thomson Method, system and apparatus for setting insulin dosages for diabetics
US20140379360A1 (en) * 2013-06-25 2014-12-25 Lifescan, Inc. Low glucose treatment for people with diabetes

Also Published As

Publication number Publication date
EP3295342B1 (en) 2021-08-25
US20180130551A1 (en) 2018-05-10
JP2018517974A (ja) 2018-07-05
CN107592931A (zh) 2018-01-16
EP3295342A1 (en) 2018-03-21
WO2016181351A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
EP3295342B1 (en) Blood glucose management device for calculating bolus insulin
CN102802522B (zh) 具有胰岛素给药安全警告的分析物测试方法和系统
JP5329562B2 (ja) 試験システム
CN1991369B (zh) 分析物检验设备
AU2011207314B2 (en) Analyte testing method and system
US9563743B2 (en) Analyte testing method and system with high and low blood glucose trends notification
US20160042136A1 (en) Blood glucose management and interface systems and methods
US20140024907A1 (en) Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
US20090149729A1 (en) Method of inputting data into analyte testing device
CN103025242B (zh) 确保关于平均餐前和餐后葡萄糖差值消息传递的统计功效的方法、系统和装置
JP2015091320A (ja) 糖尿病管理のための分析物試験方法及びデバイス
JP2010042261A (ja) 検体試験方法および検体試験システム
CN104620246A (zh) 指示胰岛素注入泵命令的血糖影响的方法和系统
US9213802B2 (en) Updatability of structured blood glucose tests performed on handheld diabetes management devices
KR20110014176A (ko) 분석물 측정 및 관리 장치 및 관련 방법
US20170242967A1 (en) Display with iconic markers for a meter
CA2961061A1 (en) Smart logging for management of health-related issues
US20140275903A1 (en) System and method for quick-access physiological measurement history
CA3039212C (en) Method for emphasizing analyte values during a therapeutic window
HK1245938A1 (en) Blood glucose management device for calculating bolus insulin
AU2015202434A1 (en) Analyte testing method and system
HK1242157A1 (en) Smart logging for management of health-related issues

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210128

FZDE Discontinued

Effective date: 20221114